NeisVac-C®

BIOLOGICAL2 trials

Sponsors

Merck Sharp & Dohme LLC, MCM Vaccines B.V.

Conditions

Bacterial InfectionsMeningitis, MeningococcalNeisseria MeningitidisRotavirus InfectionsVirus Diseases

Phase 3

RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

CompletedNCT00443846

Merck Sharp & Dohme LLCMeningitis, Meningococcal, Rotavirus Infections

Start: 2007-02-13End: 2007-10-23Updated: 2018-06-20

Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

CompletedNCT01839188

MCM Vaccines B.V.Bacterial Infections, Neisseria Meningitidis, Virus Diseases

Start: 2013-05-01End: 2014-03-19Updated: 2019-02-25

Related Papers

Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).

2017-06-0213 citations